17 Apr 2025, Thu

Breaking

US IRS planning to rescind Harvard’s tax-exempt status, CNN reports

Intel will need license to export AI chips to Chinese clients, FT reports

Zoom down for thousands of users, Downdetector shows

Foreign holdings of US Treasuries rise in February

China’s customs administration encourages companies to expand in diverse markets

N2:MRCH

N2:BIODRG N2:CMPNY N2:COVID N2:DE N2:EUROP N2:HEA N2:MRCH N2:MRCH1 N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PUBHEA N2:PUBL N2:US N2:VACCIN

About 4 million Americans got updated COVID vaccines in September

By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the updated COVID-19...

N2:BIODRG N2:CMPNY N2:COMDIS N2:COVID N2:CPROD N2:DISEAS N2:GEN N2:HEA N2:HECA N2:HUMDIS N2:INFDIS N2:MEDREG N2:MRCH N2:NAMER N2:PHMR N2:PUBHEA N2:PUBL N2:US N2:VACCIN

US govt awards $1.4 billion for development of new COVID therapies, vaccines

(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the...

N2:CMPNY N2:COVID N2:HEA N2:MRCH N2:MRCH1 N2:PUBHEA N2:PUBL N2:TOPNWS N2:US N2:VACCIN

Moderna’s updated COVID vaccine effective against ‘Eris’ variant in humans

(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine...

N2:BLR N2:CMPNY N2:CPROD N2:DRUDEV N2:HEA N2:HEADMI N2:HECA N2:MRCH N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:RHEUMA N2:SCI N2:TOPNWS N2:US

AbbVie trims forecast for Humira sales drop on favorable coverage

By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...

N2:BLR N2:CMPNY N2:COVID N2:DRUGEN N2:HEA N2:HECA N2:MEDDTE N2:MEDQ N2:MEDQ1 N2:MRCH N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:US N2:VACCIN

J&J upbeat on 2023 as devices rebound post-COVID, shares jump

By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...

N2:CMPNY N2:DEMENT N2:HEA N2:MEDCON N2:MEDREG N2:MRCH N2:MRCH1 N2:NAMER N2:PHMR N2:PUBL N2:SCI N2:US

Acumen’s Alzheimer’s drug passes initial safety test

By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...

N2:CMPNY N2:DEAL1 N2:EUROP N2:FIN N2:MRCH N2:MRCH1 N2:MRG N2:NAMER N2:PHAG08 N2:PHAR1 N2:PUBL N2:US

US FTC seeks additional info on Pfizer’s proposed takeover of Seagen

(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...

N2:ASIA N2:BIOPH N2:CMPNY N2:CPROD N2:DEMENT N2:DRUDEV N2:HEA N2:HEADMI N2:INSR N2:JP N2:MEDREG N2:MRCH N2:MTGFX N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:SCI N2:TOPNWS N2:US

US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug

By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen’s Leqembi won a...

N2:.N N2:AER N2:AERO N2:AERO1 N2:AMERS N2:BLR N2:CMPNY N2:INT N2:ITSE08 N2:MKTREP N2:MRCH N2:MRCH1 N2:NAMER N2:NEWS1 N2:PUBL N2:RCH N2:REP N2:SRCHEN N2:STX N2:TOPNWS N2:US

Wall Street slips as investors eye Russia, Fed hikes, quarter-end

By Sinéad Carew, Sruthi Shankar and Johann M Cherian (Reuters) – U.S. stocks closed lower...

N2:BLR N2:CMPNY N2:CORPD N2:DBT N2:DEAL1 N2:MRCH N2:MRCH1 N2:MRG N2:NAMER N2:PHAG08 N2:PHAR1 N2:PUBL N2:US

Pfizer to raise $31 billion for Seagen takeover in largest debt offering

(Reuters) -Pfizer Inc is planning to raise $31 billion through its largest debt offering to...

Uncategorized

US IRS planning to rescind Harvard’s tax-exempt status, CNN reports

Uncategorized

Intel will need license to export AI chips to Chinese clients, FT reports

Uncategorized

Zoom down for thousands of users, Downdetector shows

Uncategorized

Foreign holdings of US Treasuries rise in February